businesspress24.com - Healthcare & Medical: Pressemitteilungen - Kategorie - Seite NAN
 

Healthcare & Medical

Category / Healthcare & Medical


Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing

TOKYO & HAMBURG: THUNDERBEAT™ II features the versatility of three energy modes to support surgeons in adapting to challenging clinical conditions ...

Indonesia Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership

BANDUNG, INDONESIA: The 26th DCVMN Annual General Meeting, held in Bali on 29-31 October, marks a moment for Indonesia to reaffirm leadership in global health diplomacy ...

Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy Program"

TOKYO: TOKYO, Oct 21, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), today announced that the feasibility study project entitled “Feasibility study on the development of Japanese digitalized endosc ...

Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

TOKYO & HAMBURG: TOKYO & HAMBURG, Oct 6, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced t ...

Olympus Launches OLYSENSE CAD/AI in the US and Europe

TOKYO: Unlocking the Power of Intelligent Endoscopy. AI-powered tools help clinicians detect GI lesions earlier and improve care pathways ...

Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont(TM) Tyvek(R) with Renewable Attribution

TOKYO: TOKYO, Sept 30, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced a new collabo ...

EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes

Hong Kong: HONG KONG, Sep 17, 2025 - (ACN Newswire) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapi ...

Counterfeit Products Sold Online in Malaysia Threaten Halal Compliance, Consumer Health, and the E-Commerce Sector, Says Muslim Consumers Association (PPIM)

KUALA LUMPUR,: KUALA LUMPUR, Sept 18, 2025 - (ACN Newswire) - The Muslim Consumers’ Association of Malaysia today expressed deep concern over the emergence of counterfeit health products sold online with fake hala ...

HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership

Hong Kong: HONG KONG, Sep 15, 2025 - (ACN Newswire) – Hong Kong’s healthcare sector surged by nearly 30% in the last decade, with the total number of related businesses now exceeding 3,000. Details of this r ...

Everest Medicines Announces 2025 Interim Results: Dual-Engine Strategy Driving Strong Synergies Between Commercialization and R&D

HONG KONG: HONG KONG, Sep 1, 2025 - (ACN Newswire) - On August 29, Everest Medicines (1952.HK) announced its interim results for the six months ended June 30, 2025. The Company’s total revenue for the first ha ...

Everest Medicines New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

HONG KONG: HONG KONG, Aug 14, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Appl ...

AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance

Singapore: SINGAPORE, Aug 13, 2025 - (ACN Newswire) - SGX Catalist-listed AsiaMedic Limited (the “Company” and, together with its subsidiaries, the “Group”) announced its unaudited financial results for ...

Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan

HONG KONG: HONG KONG, Aug 8, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R). ...

Cornerstone Robotics Completes Worlds First Clinical Validation of Autonomous Surgery Performed by Robot-Assisted Surgery

HONG KONG: HONG KONG, Aug 6, 2025 - (ACN Newswire) - A major breakthrough in surgical embodied intelligence in Robot-Assisted Surgery (RAS) has been achieved in Hong Kong, China. At a press conference held on 5 ...

NEFECON(R) Receives NMPA Approval for Production Expansion in China, as Everest Medicines Accelerates Accessibility and Capacity Efforts

HONG KONG: HONG KONG, Aug 5, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by C ...

Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies

HONG KONG: HONG KONG, Aug 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equi ...


Page 1 von 301:  1 2  3  4  5  6  7  8  9  10  .. » 301





 

Who is online

All members: 10 590
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 106


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.